Digestive System Neoplasms: Clinical Trials

13 trials for Digestive System Neoplasms, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

13 withdrawn. 13 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 413Withdrawn 13

Follow Digestive System Neoplasms: new trials by email Literature Review of Digestive System Neoplasms trials Research Report on Digestive System Neoplasms

Trials (filtered) newest first · largest first

All 13 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Evaluate Indocyanine Green Lymphangiography to Improve Lymphadenectomy in Gastric Cancer Patients
Indocyanine green - Gastric Cancer
Phase 4WithdrawnMayo Clinic2022-01-012023-07-19
Gut Microbiome Modulation to Enable Efficacy of Checkpoint-based Immunotherapy in Pancreatic Adenocarcinoma
Pembrolizumab, Ciprofloxacin 500mg PO BID days 1-29, Metronidazole 500mg PO TID days 1-29 - Pancreatic Cancer
Phase 4WithdrawnNYU Langone Health2019-06-252020-06-26
Improving CBCT for Liver IG-SBRT Using Gadoxetate Disodium
Primovist - Primary Liver Cancer, Metastatic Liver Cancer
Phase 4WithdrawnSlawa Cwajna2017-08-012021-01-27
DAA in the Risk of Recurrence After Curative Treatment of HCC
Ledipasvir 90mg/Sofosbuvir 400 mg, Ribavirin - Hepatocellular Carcinoma
Phase 4WithdrawnTaipei Veterans General Hospital, Taiwan2016-11-012017-08-07
Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies
TriNav, Traditional Delivery, Doxorubicin - Liver Cancer
Phase 4WithdrawnDana-Farber Cancer Institute2016-07-012025-02-05
Prevention of Upper Gastrointestinal Hemorrhage Using AlbisĀ® in the Patients of Locally Advanced Pancreatic Cancer Who Underwent Concurrent Chemoradiotherapy
AlbisĀ®, Placebo - Pancreatic Ductal Adenocarcinoma
Phase 4WithdrawnYonsei University2015-10-012019-01-29
Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery
Sevoflurane, Desflurane - Hepatocellular Carcinoma, Hepatoma
Phase 4WithdrawnTokyo Medical and Dental University2014-07-012023-05-03
Genetically-informed Therapies for Patients With Metastatic Cancer
Genetically Informed Therapy - Metastatic Cancer
Phase 4WithdrawnDartmouth-Hitchcock Medical Center2014-01-012014-07-14
Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia
Travasol (amino acid injection), Insulin - Colorectal Cancer
Phase 4WithdrawnMcGill University Health Centre/Research Institute of the McGill University Health Centre2013-12-012026-10-08
Direct Peritoneal Resuscitation Plus Conventional Resuscitation
Galactose, Standard Treatment - Hepatic Cancer
Phase 4WithdrawnUniversity of Louisville2012-09-012017-05-05
Transanal Endoscopic Microsurgery Versus Endoscopic Submucosal Dissection For Large Rectal Adenomas
TEM - Transanal Endoscopic Microsurgery, ESD - Endoscopic Submucosal Dissection - RECTAL NEOPLASMS
Phase 4WithdrawnEuropean Association for Endoscopic Surgery2012-01-012023-09-08
Comparison of Bowel Preparation in Virtual Colonoscopy (VC) - Patient Experience
bowel preparation: senna & gastrofin versus picolax (standard) - Colorectal Cancer
Phase 4WithdrawnLondon North West Healthcare NHS Trust1502007-11-012010-07-26
Study Comparing Radio Frequency Ablation Plus Chemotherapy and Chemotherapy Alone in Patients With Secondary Liver Metastases
Radiofrequency Ablation (RFA), Chemotherapy - Metastatic Liver Cancer, Secondary Liver Cancer
Phase 4WithdrawnBoston Scientific Corporation2007-08-012017-03-03

Narrower conditions

Liver Neoplasms (4)  ·  Carcinoma, Hepatocellular (3)  ·  Colorectal Neoplasms (3)  ·  Pancreatic Neoplasms (2)  ·  Brain Neoplasms (1)  ·  Breast Neoplasms (1)  ·  Cholangiocarcinoma (1)  ·  Gallbladder Neoplasms (1)  ·  Gastrointestinal Neoplasms (1)  ·  Head and Neck Neoplasms (1)  ·  Hepatitis C, Chronic (1)  ·  Hyperinsulinism (1)  ·  Lung Neoplasms (1)  ·  Melanoma (1)  ·  Neoplasm Metastasis (1)

Broader conditions

Digestive System Diseases (13)  ·  Neoplasms (13)  ·  Neoplasms by Site (13)  ·  Gastrointestinal Diseases (6)  ·  Liver Diseases (6)  ·  Gastrointestinal Neoplasms (5)  ·  Intestinal Diseases (4)  ·  Intestinal Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Rectal Diseases (4)  ·  Adenocarcinoma (3)  ·  Carcinoma (3)  ·  Colonic Diseases (3)  ·  Endocrine Gland Neoplasms (3)

Interventions

Amino Acids (1)  ·  Ciprofloxacin (1)  ·  Desflurane (1)  ·  Doxorubicin (1)  ·  Drug Therapy (1)  ·  Galactose (1)  ·  Indocyanine Green (1)  ·  Insulin (1)  ·  Metronidazole (1)  ·  Patient-Specific Modeling (1)  ·  Radiofrequency Ablation (1)  ·  Radionuclide Generators (1)  ·  Ribavirin (1)  ·  Sevoflurane (1)  ·  Sofosbuvir (1)

Sponsors

Boston Scientific Corporation (1)  ·  Dana-Farber Cancer Institute (1)  ·  Dartmouth-Hitchcock Medical Center (1)  ·  European Association for Endoscopic Surgery (1)  ·  London North West Healthcare NHS Trust (1)  ·  Mayo Clinic (1)  ·  McGill University Health Centre/Research Institute of the McGill University Health Centre (1)  ·  NYU Langone Health (1)  ·  Slawa Cwajna (1)  ·  Taipei Veterans General Hospital, Taiwan (1)  ·  Tokyo Medical and Dental University (1)  ·  University of Louisville (1)  ·  Yonsei University (1)

Countries

United States (6)  ·  Canada (2)  ·  Italy (1)  ·  Japan (1)  ·  United Kingdom (1)

Top investigators

David Burling (1)  ·  Deidre Cohen (1)  ·  Dmitry Rabkin, MD, PhD (1)  ·  Enrique F Elli, MD (1)  ·  Jason Smith, MD (1)  ·  Koshi Makita, M.D. (1)  ·  Mario Morino, Prof of Surgery (1)  ·  Mary D Chamberlin, MD (1)  ·  Slawa Cwajna, MD (1)  ·  Thomas Schricker, MD (1)  ·  William Jacqmein (1)  ·  Yi-Hsiang Huang, MD, PhD (1)

Results publications

PMID 10950834, PMID 37526194